RE:RE:RE:News Out On Tuesday
I agree....The 2022 market meltdown & the one brewing currently act like anchors on the sp, but on the flip side, they offer impact-minded investors great buying opportunities, especially in this type of specialized market where gold is buried in anonymity.
It's rare to see any pre-revenue "smaller" biotech continue to amble forward with such low R&D costs despite the exposure to recessionary pressures & the general market anonymity. One investor's risk/trash is another's treasure/opportunity. Fortunately for us, our treasure has been hidden. Should have another nice buy signal coming next week....all imo.